Medicare Enrolled
Dr. Kaditam Reddy, MD
Neurology · Thousand Oaks, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reddy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reddy
Dr. Kaditam Reddy is a neurology specialist in Thousand Oaks, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Reddy performed 13,078 Medicare services across 1,223 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reddy received a total of $17,907 from 84 pharmaceutical and/or device companies across 1029 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in CA
$17,907 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,078
Medicare services
Top 8% in CA for neurology
1,223
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~654 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
11,200 | $5 | $13 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
838 | $101 | $237 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
320 | $147 | $316 |
| New patient office visit, complex (60-74 min) | 149 | $179 | $453 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
133 | $100 | $224 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
84 | $54 | $146 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
69 | $66 | $166 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
54 | $107 | $290 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
48 | $355 | $861 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
44 | $109 | $331 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
43 | $144 | $430 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
39 | $129 | $327 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
36 | $146 | $434 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
21 | $88 | $223 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$17,907
Total received (2018-2024)
Avg $2,558/year across 7 years
Top 16% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
1,029
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,842 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$65 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,469
2023
$2,984
2022
$3,184
2021
$2,951
2020
$1,888
2019
$1,809
2018
$1,622
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$412
PFIZER INC.
$345
CSL Behring
$248
Teva Pharmaceuticals USA, Inc.
$213
EMD Serono, Inc.
$175
Biogen, Inc.
$160
UCB, Inc.
$156
Celgene Corporation
$147
SK Life Science, Inc.
$136
Novartis Pharmaceuticals Corporation
$125
Merz Pharmaceuticals, LLC
$119
Neurocrine Biosciences, Inc.
$106
ARGENX US, INC.
$97
TG Therapeutics, Inc.
$84
Lilly USA, LLC
$81
Azurity Pharmaceuticals, Inc.
$79
Neurelis, Inc.
$74
Otsuka America Pharmaceutical, Inc.
$66
Genentech, Inc.
$64
ANI Pharmaceuticals, Inc.
$63
Genentech USA, Inc.
$57
Eisai Inc.
$56
Acorda Therapeutics, Inc
$52
MDD US Operations, LLC
$49
Alexion Pharmaceuticals, Inc.
$49
ACADIA Pharmaceuticals Inc
$41
Octapharma USA, Inc.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$27
Alnylam Pharmaceuticals Inc.
$27
Boston Scientific Corporation
$25
Lundbeck LLC
$22
Sumitomo Pharma America, Inc.
$19
AstraZeneca Pharmaceuticals LP
$17
SCILEX PHARMACEUTICALS INC.
$16
Grifols USA, LLC
$15
Kyowa Kirin, Inc.
$13
Top 3 companies account for 29.0% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,166
ABBVIE INC.
$1,160
Teva Pharmaceuticals USA, Inc.
$995
EMD Serono, Inc.
$983
Amgen Inc.
$822
Novartis Pharmaceuticals Corporation
$809
CSL Behring
$709
PFIZER INC.
$604
Lundbeck LLC
$518
Neurocrine Biosciences, Inc.
$510
SK Life Science, Inc.
$460
Allergan, Inc.
$371
Lilly USA, LLC
$368
UCB, Inc.
$366
Genentech USA, Inc.
$359
Eisai Inc.
$339
Supernus Pharmaceuticals, Inc.
$321
Alexion Pharmaceuticals, Inc.
$320
GENZYME CORPORATION
$302
MDD US Operations, LLC
$279
Acorda Therapeutics, Inc
$277
Amneal Pharmaceuticals LLC
$274
Kyowa Kirin, Inc.
$262
ARGENX US, INC.
$244
Grifols USA, LLC
$237
ACADIA Pharmaceuticals Inc
$229
Merz Pharmaceuticals, LLC
$225
Takeda Pharmaceuticals U.S.A., Inc.
$218
AbbVie Inc.
$213
US WorldMeds, LLC
$197
Biohaven Pharmaceutical Holding Company Ltd.
$196
Biohaven Pharmaceuticals, Inc.
$186
Sumitomo Pharma America, Inc.
$176
Allergan Inc.
$168
Janssen Pharmaceuticals, Inc
$161
Celgene Corporation
$147
EISAI INC.
$146
Avanir Pharmaceuticals, Inc.
$141
LivaNova USA, Inc.
$130
Otsuka America Pharmaceutical, Inc.
$116
Neurelis, Inc.
$111
Azurity Pharmaceuticals, Inc.
$109
Adamas Pharmaceuticals, Inc.
$109
JAZZ PHARMACEUTICALS INC.
$99
AstraZeneca Pharmaceuticals LP
$97
Almatica Pharma LLC
$95
Sunovion Pharmaceuticals Inc.
$90
ARBOR PHARMACEUTICALS, INC.
$86
Assertio Therapeutics, Inc.
$86
TG Therapeutics, Inc.
$84
Merz North America, Inc.
$74
Mallinckrodt LLC
$71
Horizon Therapeutics plc
$71
UPSHER-SMITH LABORATORIES LLC
$68
Genentech, Inc.
$64
ANI Pharmaceuticals, Inc.
$63
Abbott Laboratories
$60
Alnylam Pharmaceuticals Inc.
$57
Vertiflex, Inc.
$54
IMPEL PHARMACEUTICALS INC.
$46
Octapharma USA, Inc.
$45
IBSA Pharma Inc.
$40
Zyla Life Sciences
$38
Arbor Pharmaceuticals, Inc.
$38
Zyla Life Sciences, Inc.
$36
Vertical Pharmaceuticals, LLC
$35
Banner Life Sciences, LLC
$35
TG THERAPEUTICS, INC.
$31
CATALYST PHARMACEUTICALS, INC.
$28
Boston Scientific Corporation
$25
Bio Products Laboratory USA, Inc.
$25
MERZ NORTH AMERICA, INC.
$23
Impax Laboratories, Inc.
$23
Mitsubishi Tanabe Pharma America, Inc.
$22
Scilex Pharmaceuticals Inc.
$22
Medtronic Vascular, Inc.
$21
Axsome Therapeutics, Inc.
$19
SCILEX PHARMACEUTICALS INC.
$16
Promius Pharma LLC
$15
Jazz Pharmaceuticals Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$15
Catalyst Pharmaceuticals, Inc.
$14
Avion Pharmaceuticals
$13
ASSERTIO THERAPEUTICS, Inc.
$11
Top 3 companies account for 18.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aduhelm · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · CAMBIA · COMIRNATY · COPAXONE · Cambia · DIVIGEL · DUOPA · Dayvigo · Dhivy · EMGALITY · Edarbi · Enspryng · FIRDAPSE · Fycompa · GAMMAGARD · GENERAL - DBS · GOCOVRI · GRALISE · Gammaplex · Gamunex-C · Gocovri · Gralise · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PAXLOVID · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · REXULTI · REYVOW · RYTARY · Radicava · Rebif · Repatha · Reveal LINQ · SOLIRIS · SPRIX · SUNOSI · Soliris · Sunosi · Superion ISS · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Tirosint · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · XADAGO · XEOMIN · XYREM · Xadago · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
84
Per 100K population
10.0
County median income
$107,327
Nearest hospital
LOS ROBLES HOSPITAL & MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reddy is a mixed practice specialist, with above-average Medicare volume (top 8% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reddy experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Reddy performed 11,200 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reddy receive payments from pharmaceutical companies?
Yes. Dr. Reddy received a total of $17,907 from 84 companies across 1,029 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reddy's costs compare to other neurologists in Thousand Oaks?
Dr. Reddy's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Thousand Oaks
Browse neurologists in Thousand Oaks ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology